Advertisements


Novartis Delivers In Breast Cancer Study, Could Lead To A Major Battle With Competitors

Novartis Delivers In Breast Cancer Study, Could Lead To A Major Battle With Competitors.....»»

Category: topSource: seekingalphaOct 9th, 2019

Merck"s Keytruda Shines In Breast Cancer Study, Could Possibly Lead To Accelerated Approval

Merck"s Keytruda Shines In Breast Cancer Study, Could Possibly Lead To Accelerated Approval.....»»

Category: topSource: seekingalphaOct 2nd, 2019

Taylor Swift reveals her mom has been diagnosed with a brain tumor amid her second battle with breast cancer

Cooper Neill/Getty I.....»»

Category: topSource: businessinsiderJan 21st, 2020

Could This Breast Cancer Study Be the Next Big Thing?

Immunomedics shares made a handy gain on Thursday after the company announced that the FDA has accepted its Biologics License Application for its breast cancer treatment......»»

Category: blogSource: 247wallstDec 26th, 2019

Myriad Genetics says study validates polygenic risk score for breast cancer

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 14th, 2019

Why These Breast Cancer Study Results Look So Promising

Puma Biotechnology shares made a handy gain early on Thursday after the company presented updated results from its Phase 2 Summit clinical trial of neratinib at the 2019 San Antonio Breast Cancer........»»

Category: blogSource: 247wallstDec 12th, 2019

Seattle Genetics says tucatinib shows statistical benefit in breast cancer study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 11th, 2019

Permanent hair dye and straighteners may increase breast cancer risk by messing with our hormones

Thomas Barwick via Getty Images A new study of more than 46.....»»

Category: topSource: businessinsiderDec 4th, 2019

Tilray Backs First Human Study On Medical Marijuana Used For Breast Cancer Drug Side Effects

Tilray, Inc. (NASDAQ: TLRY) announced Thursday it has imported medical cannabis into the U.S. from Canada to back a new clinical trial. read more.....»»

Category: blogSource: benzingaOct 24th, 2019

Seattle Genetics Rallies To Record High On Positive Results From Midstage Breast Cancer Study

Shares of the large-cap biopharma Seattle Genetics, Inc. (NASDAQ: SGEN) were advancing strongly Monday following a clinical trial readout from the company. read more.....»»

Category: blogSource: benzingaOct 21st, 2019

Atossa Genetics receives IRB approval for Phase 2 breast cancer study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 16th, 2019

The Agenda: A major grant for Roswell, fiscal tightening for Niagara Falls and a rainy Wednesday

MORNING LEAD Roswell Park Comprehensive Cancer Center will move ahead with a three-part strategy to treat advanced cancers with help from a federal grant. The four-year $6.42 million Breakthrough Award comes from the U.S. Department of Defense’s.....»»

Category: topSource: bizjournalsOct 2nd, 2019

Nektar breast cancer data "promising," warrants more study, says Piper Jaffray

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 26th, 2019

AI is improving the accuracy of breast cancer detection

As artificial intelligence is poised to change a number of industries, a new study shows promise of its use in more accurately detecting certain types of breast cancer.  Researchers at the University of California-Los Angeles have developed an A.....»»

Category: topSource: bizjournalsAug 14th, 2019

Xoma"s gevokizumab used to dose first patient in cancer study by Novartis

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 13th, 2019

Novartis Gets FDA Nod for Breast Cancer Drug & Gene Therapy

Zacks.....»»

Category: topSource: redinewsMay 27th, 2019

FDA approves Novartis" Piqray for breast cancer

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 24th, 2019

Novartis gets FDA nod for advanced breast-cancer treatment

Novartis AG said late Friday the U.S. Food and Drug Administration has approved one of its treatments for a type of advanced breast cancer afflicting patients carrying a gene.....»»

Category: topSource: marketwatchMay 24th, 2019

OncoSec reports interim data from Keynote-890 study of breast cancer combination

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 22nd, 2019

Solid Breast Cancer Results From MacroGenics Ahead of ASCO

MacroGenics announced additional details of the results from the Phase 3 Sophia study of margetuximab in patients with HER2-positive metastatic breast cancer who have previously been treated with........»»

Category: blogSource: 247wallstMay 16th, 2019

Myriad announces findings from EndoPredict study in early stage breast cancer

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 9th, 2019